Cargando…

Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease is a multifaceted disease that progresses through multiple phases; it involves metabolic as well as structural changes. These alterations can be measured directly or indirectly through blood, non-invasive imaging, and/or tissue analyses. While some studies have eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamshidi, Neema, Feizi, Alborz, Sirlin, Claude B., Lavine, Joel E., Kuo, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456937/
https://www.ncbi.nlm.nih.gov/pubmed/37623872
http://dx.doi.org/10.3390/metabo13080929
_version_ 1785096819331563520
author Jamshidi, Neema
Feizi, Alborz
Sirlin, Claude B.
Lavine, Joel E.
Kuo, Michael D.
author_facet Jamshidi, Neema
Feizi, Alborz
Sirlin, Claude B.
Lavine, Joel E.
Kuo, Michael D.
author_sort Jamshidi, Neema
collection PubMed
description Non-alcoholic fatty liver disease is a multifaceted disease that progresses through multiple phases; it involves metabolic as well as structural changes. These alterations can be measured directly or indirectly through blood, non-invasive imaging, and/or tissue analyses. While some studies have evaluated the correlations between two sets of measurements (e.g., histopathology with cross-sectional imaging or blood biomarkers), the interrelationships, if any, among histopathology, clinical blood profiles, cross-sectional imaging, and metabolomics in a pediatric cohort remain unknown. We created a multiparametric clinical MRI–histopathologic NMR network map of pediatric NAFLD through multimodal correlation networks, in order to gain insight into how these different sets of measurements are related. We found that leptin and other blood markers were correlated with many other measurements; however, upon filtering out the blood biomarkers, the network was decomposed into three independent hubs centered around histopathological features, each with associated MRI and plasma metabolites. These multi-modality maps could serve as a framework for characterizing disease status and progression and could potentially guide medical interventions.
format Online
Article
Text
id pubmed-10456937
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104569372023-08-26 Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease Jamshidi, Neema Feizi, Alborz Sirlin, Claude B. Lavine, Joel E. Kuo, Michael D. Metabolites Article Non-alcoholic fatty liver disease is a multifaceted disease that progresses through multiple phases; it involves metabolic as well as structural changes. These alterations can be measured directly or indirectly through blood, non-invasive imaging, and/or tissue analyses. While some studies have evaluated the correlations between two sets of measurements (e.g., histopathology with cross-sectional imaging or blood biomarkers), the interrelationships, if any, among histopathology, clinical blood profiles, cross-sectional imaging, and metabolomics in a pediatric cohort remain unknown. We created a multiparametric clinical MRI–histopathologic NMR network map of pediatric NAFLD through multimodal correlation networks, in order to gain insight into how these different sets of measurements are related. We found that leptin and other blood markers were correlated with many other measurements; however, upon filtering out the blood biomarkers, the network was decomposed into three independent hubs centered around histopathological features, each with associated MRI and plasma metabolites. These multi-modality maps could serve as a framework for characterizing disease status and progression and could potentially guide medical interventions. MDPI 2023-08-08 /pmc/articles/PMC10456937/ /pubmed/37623872 http://dx.doi.org/10.3390/metabo13080929 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jamshidi, Neema
Feizi, Alborz
Sirlin, Claude B.
Lavine, Joel E.
Kuo, Michael D.
Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
title Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
title_full Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
title_fullStr Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
title_full_unstemmed Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
title_short Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
title_sort multi-modality, multi-dimensional characterization of pediatric non-alcoholic fatty liver disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456937/
https://www.ncbi.nlm.nih.gov/pubmed/37623872
http://dx.doi.org/10.3390/metabo13080929
work_keys_str_mv AT jamshidineema multimodalitymultidimensionalcharacterizationofpediatricnonalcoholicfattyliverdisease
AT feizialborz multimodalitymultidimensionalcharacterizationofpediatricnonalcoholicfattyliverdisease
AT sirlinclaudeb multimodalitymultidimensionalcharacterizationofpediatricnonalcoholicfattyliverdisease
AT lavinejoele multimodalitymultidimensionalcharacterizationofpediatricnonalcoholicfattyliverdisease
AT kuomichaeld multimodalitymultidimensionalcharacterizationofpediatricnonalcoholicfattyliverdisease